Stay updated on Nivolumab in ER+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in ER+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in ER+ Breast Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The clinical trial record for the completed nivolumab-versus-placebo breast cancer study is now displayed, with study details, eligibility criteria, outcome measures, locations, and related publications.
    Difference
    100%
    Check dated 2026-11-08T02:33:24.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.8.0 instead of v3.7.2, while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T22:30:28.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    A banner announces NIH website updates and a terminology change from “Artificial Intelligence” to “Super Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-24T22:24:30.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision indicator changes from v3.7.1 to v3.7.2; the page still displays a 403 error.
    Difference
    0.2%
    Check dated 2026-10-17T22:28:37.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The footer’s site revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-10T22:16:54.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Access to the study record now displays a 403 Forbidden page, replacing the usual study details and navigation. The change prevents viewing the study content on this page.
    Difference
    18%
    Check dated 2026-09-19T20:36:25.000Z thumbnail image

Stay in the know with updates to Nivolumab in ER+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in ER+ Breast Cancer Clinical Trial page.